Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 5 von 692
Nature reviews cardiology, 2023-09, Vol.20 (9), p.600-616
2023
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
Ist Teil von
  • Nature reviews cardiology, 2023-09, Vol.20 (9), p.600-616
Ort / Verlag
England
Erscheinungsjahr
2023
Quelle
MEDLINE
Beschreibungen/Notizen
  • Lowering the levels of LDL cholesterol in the plasma has been shown to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). Several other lipoproteins, such as triglyceride-rich lipoproteins, HDL and lipoprotein(a) are associated with atherosclerosis and ASCVD, with strong evidence supporting causality for some. In this Review, we discuss novel and upcoming therapeutic strategies targeting different pathways in lipid metabolism to potentially attenuate the risk of cardiovascular events. Key proteins involved in lipoprotein metabolism, such as PCSK9, angiopoietin-related protein 3, cholesteryl ester transfer protein and apolipoprotein(a), have been identified as viable targets for therapeutic intervention through observational and genetic studies. These proteins can be targeted using a variety of approaches, such as protein inhibition or interference, inhibition of translation at the mRNA level (with the use of antisense oligonucleotides or small interfering RNA), and the introduction of loss-of-function mutations through base editing. These novel and upcoming strategies are complementary to and could work synergistically with existing therapies, or in some cases could potentially replace therapies, offering unprecedented opportunities to prevent ASCVD. Moreover, a major challenge in the prevention and treatment of non-communicable diseases is how to achieve safe, long-lasting reductions in causal exposures. This challenge might be overcome with approaches such as small interfering RNAs or genome editing, which shows how far the field has advanced from when the burden of achieving this goal was placed upon patients through rigorous adherence to daily small-molecule drug regimens.
Sprache
Englisch
Identifikatoren
ISSN: 1759-5002
eISSN: 1759-5010
DOI: 10.1038/s41569-023-00860-8
Titel-ID: cdi_crossref_primary_10_1038_s41569_023_00860_8

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX